Background illustration for clinical trials search

Paid Clinical Trials Washington State

Discover 1,593 paid clinical trials in Washington State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Burlington MA, Commack NY, Uniondale NY, Harrison NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase2, Recruiting

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

for
Relapsing Remitting Multiple Sclerosis
Location: Baltimore MD, Morgantown WV, Atlanta GA, Milwaukee WI,
Sponsor: SetPoint Medical Corporation

Sex: All

Age: 22 - 60

Code: NCT06796504

Recruiting

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

for
Congenital Heart Disease, Congenital Heart Disease (CHD)
Location: Philadelphia PA, Columbus OH, Cincinnati OH, Houston TX,
Sponsor: Starlight Cardiovascular Inc

Sex: All

Age: 0

Code: NCT07114718

Recruiting

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

for
Primary Progressive Multiple Sclerosis,
Location: New York NY, Durham NC, Cincinnati OH, St Louis MO,
Sponsor: Tr1X, Inc.

Sex: All

Age: 18 - 65

Code: NCT07477639

Phase1, Phase2, Recruiting

Copper Supplementation in Cirrhosis

for
Cirrhosis, Chronic Liver Disease, Fibrosis, Infection
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07471542

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma

for
Hepatocellular Carcinoma (HCC)
Location: Margate FL, Orange City FL, Houston TX, Tacoma WA,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18 - 65

Code: NCT07176650

Phase1, Recruiting

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

for
Adenovirus Infections
Location: Boston MA, New Hyde Park NY, New York NY, Hackensack NJ,
Sponsor: SymBio Pharmaceuticals

Sex: All

Age: 0+

Code: NCT07387367

Phase3, Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

for
Dystonia
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Vima Therapeutics

Sex: All

Age: 18 - 70

Code: NCT07304089

Phase2, Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

for
Non-Muscle Invasive Bladder Neoplasms
Location: Bryn Mawr PA, Syracuse NY, North Charleston SC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07309445

Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Boston MA, Quebec, Sherbrooke, New York NY, Montreal,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07277231

Phase3, Recruiting

Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians

for
Ovarian Carcinoma, Psychiatric Disorder
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07282158

Recruiting

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06998940

Phase3, Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma,
Location: Moncton, Quebec, New York NY, East Brunswick NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07431281

Phase3, Recruiting

Hemophilia A Research Program

for
Hemophilia A, Hemophilia A, Severe, Factor VIII (FVIII),
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 0+

Code: NCT07414511

Recruiting

Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms

for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07148947

Phase2, Recruiting

Comparison of Outcomes of Management of Bowel Obstruction

for
Adhesive Small Bowel Obstruction
Location: New York NY, Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07084441

Recruiting

Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area

for
Anastomotic Leaks, Hartmanns Stump Leakage
Location: New York NY, Hershey PA, Huntington WV, Seattle WA
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07035431

Recruiting

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

for
Osteoarthritis, Overweight or Obesity
Location: Quincy MA, Burlington MA, Quebec, Victoriaville,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07353931

Phase3, Recruiting

The "What Is Important to Us" Communication Intervention Pilot Clinical Trial

for
Critical Illness, Neurologic Disorder
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0+

Code: NCT06208332

Phase2, Recruiting

Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma

for
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07224100

Phase2, Recruiting

Popular cities in Washington State

SpokaneBellinghamSeattleKentEverettTacomaRenton